Literature DB >> 18612214

Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.

P C Ng1, C W K Lam, C H Lee, I H S Chan, S P S Wong, T F Fok.   

Abstract

BACKGROUND: High-dose systemic dexamethasone is effective in facilitating extubation of ventilated infants with bronchopulmonary dysplasia. Although the suppression and recovery of pituitary-adrenal response had been assessed after corticosteroid treatment in very low birth weight infants, its effect on hypothalamic function has not been longitudinally monitored. AIMS: This study was designed to assess the longitudinal hypothalamic response before, during and 4 weeks after a 3-week dose-tapering course of systemic dexamethasone treatment. PATIENTS AND METHODS: Twenty very low birth weight infants had blood collected for corticotropin-releasing hormone, ACTH and cortisol measurements immediately before starting dexamethasone (week 0), after receiving the maximum dose of treatment (week 1), at the end of the 3-week course (week 3) and 4 weeks after stopping corticosteroids (week 7).
RESULTS: All circulating hormone concentrations were significantly suppressed during the treatment period at week 1 and week 3 compared with pretreatment concentrations at week 0 (p < 0.001). The recovery of pituitary function started early soon after week 1, whereas that of hypothalamus and adrenal functions started after the end of the dexamethasone course. Plasma ACTH concentration at week 7 had returned to the pretreatment level, but plasma corticotropin-releasing hormone (p < 0.05) and serum cortisol (p < 0.001) concentrations remained significantly suppressed. Partial recovery of hypothalamic and adrenal function was observed at week 7 (62 vs. 36% of their pretreatment levels, respectively).
CONCLUSION: Our findings suggest that the hypothalamic function is suppressed during systemic corticosteroid treatment but partial recovery occurs 4 weeks after stopping therapy. Even in preterm infants, the hypothalamic-pituitary-adrenal axis behaves in a similar manner as in adult subjects and the pituitary function recovers earlier than that of hypothalamus and adrenals. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612214     DOI: 10.1159/000143396

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  3 in total

1.  Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in Rats.

Authors:  Linjing Zhao; Aihua Zhao; Tianlu Chen; Wenlian Chen; Jiajian Liu; Runmin Wei; Jing Su; Xuelan Tang; Keyi Liu; Ran Zhang; Guoxiang Xie; Jun Panee; Mingfeng Qiu; Wei Jia
Journal:  J Proteome Res       Date:  2016-06-20       Impact factor: 4.466

2.  Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood.

Authors:  Delia M Vázquez; Charles R Neal; Paresh D Patel; Niko Kaciroti; Juan F López
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

Review 3.  Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia.

Authors:  Zeyar T Htun; Elizabeth V Schulz; Riddhi K Desai; Jaime L Marasch; Christopher C McPherson; Lucy D Mastrandrea; Alan H Jobe; Rita M Ryan
Journal:  J Perinatol       Date:  2021-05-19       Impact factor: 2.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.